Physician Guidance on the Use of Off-Labeled Drugs in Intrathecal Drug Delivery Systems for Chronic Pain

Timothy Deer*, Phillip Kim, Jason E. Pope, Salim Hayek, Gladstone McDowell, Nagy Mekhail, Sudhir Diwan, Michael Saulino, Susan Moeschler, David Schultz, Karina Gritsenko, Joshua Prager, Erika A. Peterson, Peter Staats, Lawrence Poree, Michael A. Fishman, Ricardo Vallejo, Aaron Calodney, Konstantin Slavin, Oscar de Leon CassadalaRobert Levy, Asokumar Buvanendran, B. Todd Sitzman, Dawood Sayed, F. Michael Ferrante, David Kloth, Christopher J. Gilligan, Leonardo Kapural, Daniel R. Kloster, Michael Leong, Joshua M. Rosenow, Tim J. Lamer, Lisa Stearns

*Corresponding author for this work

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)765-768
Number of pages4
JournalNeuromodulation
Volume22
Issue number7
DOIs
StatePublished - Oct 1 2019

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Deer, T., Kim, P., Pope, J. E., Hayek, S., McDowell, G., Mekhail, N., Diwan, S., Saulino, M., Moeschler, S., Schultz, D., Gritsenko, K., Prager, J., Peterson, E. A., Staats, P., Poree, L., Fishman, M. A., Vallejo, R., Calodney, A., Slavin, K., ... Stearns, L. (2019). Physician Guidance on the Use of Off-Labeled Drugs in Intrathecal Drug Delivery Systems for Chronic Pain. Neuromodulation, 22(7), 765-768. https://doi.org/10.1111/ner.12961